Chai Discovery CEO Interview: AI Drug Discovery is the Strongest Argument for Rapid AI Development
chaitjo · x · 2026-08-11
An in-depth interview with Josh Meier, co-founder & CEO of Chai Discovery.
- Background: Josh previously trained language models at OpenAI and built the first protein transformer at Meta.
- Company Status: Chai Discovery is 2 years old, has a 30-person team, and is valued at $3.8B. They are designing drugs for Eli Lilly, Pfizer, and Novartis.
- Core View: He believes AI's potential to cure complex diseases is the strongest and unequivocally positive argument for rapid AI development. He feels a moral obligation to pursue this future.
More from Companies & People
- AI Turns 8 Engineers Into 4 Teams: Product Management Is the New Bottleneck — rseroter · 2026-08-11
- Developer Slams Anthropic After Unexplained Account Suspension — yacineMTB · 2026-08-11
- Harvard's Rajpurkar Lab Hiring: Focusing on Medical AI for Complex Clinical Work — pranavrajpurkar · 2026-08-11
- Ex-Googler Warns: Losing Jeff Dean's Pulling Power Will Trigger a Blood Bath — MannyKayy · 2026-08-11
- Community Memes: Meta Gives Away Free Local AI, Anthropic Raises Prices — InternationalGap3698 · 2026-08-11
- NVIDIA CUTLASS Core Maintainer Steps Down, Driving GPU Inference Innovation — bingxu_ · 2026-08-11